Winslow Evans & Crocker’s Teladoc Health TDOC Stock Holding History

Winslow Evans & Crocker’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$43K	Buy	215 +190	+760%	+$38.6K	0.01%	634
2020 Q3	$5K	Buy	+25	New	+$5.29K	﹤0.01%	892
2020 Q2	–	Sell	-206	Closed	-$32K	–	1168
2020 Q1	$32K	Hold	206	–	–	0.01%	511
2019 Q4	$18K	Hold	206	–	–	﹤0.01%	693
2019 Q3	$14K	Buy	206 +70	+51%	+$4.61K	﹤0.01%	729
2019 Q2	$10K	Hold	136	–	–	﹤0.01%	844
2019 Q1	$8K	Hold	136	–	–	﹤0.01%	888
2018 Q4	$8K	Buy	136 +106	+353%	+$6.49K	﹤0.01%	836
2018 Q3	$4K	Hold	30	–	–	﹤0.01%	975
2018 Q2	$2K	Hold	30	–	–	﹤0.01%	1074
2018 Q1	$1.21K	Hold	30	–	–	﹤0.01%	1056
2017 Q4	$1.05K	Buy	+30	New	+$996	﹤0.01%	1065

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Evans & Crocker's TDOC Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Teladoc Health (TDOC) stake by 760% in Q4 2020, buying an estimated $38.6K and bringing the position to 215 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #634.

Winslow Evans & Crocker first reported a position in TDOC in Q4 2017 and has held it in 12 quarters since. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Winslow Evans & Crocker held 215 shares of Teladoc Health worth $43K as of Q4 2020.
Winslow Evans & Crocker bought 190 Teladoc Health shares in Q4 2020, an estimated $38.6K.
Teladoc Health made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #634 holding.
Winslow Evans & Crocker first reported a position in Teladoc Health in Q4 2017 and has held it in 12 quarters since.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.